The calux (chemical-activated luciferase expression) assay adapted and validated for measuring TCDD equivalents in blood plasma

Albertinka J. Murk, Pim E G Leonards, Astrid S. Bulder, Arjen S. Jonas, Marcel J C Rozemeijer, Michael S. Denison, Jan H. Koeman, Abraham Brouwer

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

A method was developed to isolate lipophilic compounds efficiently from small aliquots of blood plasma and test these for total dioxin-like toxic potency using recombinant rat (H4IIE) and mouse (Hepa1c1c7) hepatoma cell lines, containing the firefly (Photinus pyralis) luciferase gene under trans- activational control of the aryl hydrocarbon receptor (AhR). For this experiment, blood plasma was used originating from eider ducks (Somateria mollissima) that had been dosed with 3,3',4,4'-tetrachlorobiphenyl (PCB-77) or with the technical PCB-mixture Clophen A50. For each sample the CALUX (chemical-activated luciferase expression) response of both the fat- containing organic extract and the fat-free, cleaned extract were compared with data from chemical analyses of these samples. The CALUX responses for the extracts were converted into so-called CALUX TEQs (TCDD equivalents), using a 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) standard curve. The CALUX TEQs in both fatty and cleaned extracts correlated significantly with PCB-77 or PCB-153 levels (depending on the dosage group) determined in blood plasma using gas chromatography-mass spectrometry (GC-MS). For PCB-77 a toxic equivalency factor (TEF) of 1.5 x 10-3 was calculated based on these correlations. In addition, PCB-118 and PCB-156 levels in abdominal fat (assessed with GC with electron capture detection) and hepatic ethoxyresorufin O-deethylase activities correlated well with the CALUX TEQs in both fatty and cleaned blood plasma extracts, suggesting the TEQ levels in blood offer a good measure for internal dose. Plasma cholesterol and triglyceride levels were determined as a measure of lipid content, in 10-μl aliquots of blood plasma using enzymatic spectrophotometric determination. In conclusion, we have demonstrated that the CALUX assay is a rapid, sensitive assay for assessing the toxic potency of (mixtures of) AhR-active compounds in small aliquots of blood plasma. The limit of detection for the CALUX assay is currently less than 0.1 fmol (32 fg) TEQ, which corresponds with the amount of TEQs present in 0.1 to 1 ml of blood plasma in environmentally exposed species or man.

Original languageEnglish (US)
Pages (from-to)1583-1589
Number of pages7
JournalEnvironmental Toxicology and Chemistry
Volume16
Issue number8
DOIs
StatePublished - Aug 1997

Fingerprint

3,4,3',4'-tetrachlorobiphenyl
Luciferases
dioxin
Assays
Blood
blood
TCDD
PCB
assay
Plasmas
plasma
Poisons
fat
Aryl Hydrocarbon Receptors
2,4,5,2',4',5'-hexachlorobiphenyl
Fats
Fireflies
Plasma Gases
hydrocarbon
Abdominal Fat

Keywords

  • Biomarker
  • Blood plasma
  • Lipids
  • PHAH
  • Reporter gene assay

ASJC Scopus subject areas

  • Environmental Science(all)
  • Environmental Chemistry
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

The calux (chemical-activated luciferase expression) assay adapted and validated for measuring TCDD equivalents in blood plasma. / Murk, Albertinka J.; Leonards, Pim E G; Bulder, Astrid S.; Jonas, Arjen S.; Rozemeijer, Marcel J C; Denison, Michael S.; Koeman, Jan H.; Brouwer, Abraham.

In: Environmental Toxicology and Chemistry, Vol. 16, No. 8, 08.1997, p. 1583-1589.

Research output: Contribution to journalArticle

Murk, Albertinka J. ; Leonards, Pim E G ; Bulder, Astrid S. ; Jonas, Arjen S. ; Rozemeijer, Marcel J C ; Denison, Michael S. ; Koeman, Jan H. ; Brouwer, Abraham. / The calux (chemical-activated luciferase expression) assay adapted and validated for measuring TCDD equivalents in blood plasma. In: Environmental Toxicology and Chemistry. 1997 ; Vol. 16, No. 8. pp. 1583-1589.
@article{b111570bdf0043679e87515b61e80ead,
title = "The calux (chemical-activated luciferase expression) assay adapted and validated for measuring TCDD equivalents in blood plasma",
abstract = "A method was developed to isolate lipophilic compounds efficiently from small aliquots of blood plasma and test these for total dioxin-like toxic potency using recombinant rat (H4IIE) and mouse (Hepa1c1c7) hepatoma cell lines, containing the firefly (Photinus pyralis) luciferase gene under trans- activational control of the aryl hydrocarbon receptor (AhR). For this experiment, blood plasma was used originating from eider ducks (Somateria mollissima) that had been dosed with 3,3',4,4'-tetrachlorobiphenyl (PCB-77) or with the technical PCB-mixture Clophen A50. For each sample the CALUX (chemical-activated luciferase expression) response of both the fat- containing organic extract and the fat-free, cleaned extract were compared with data from chemical analyses of these samples. The CALUX responses for the extracts were converted into so-called CALUX TEQs (TCDD equivalents), using a 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) standard curve. The CALUX TEQs in both fatty and cleaned extracts correlated significantly with PCB-77 or PCB-153 levels (depending on the dosage group) determined in blood plasma using gas chromatography-mass spectrometry (GC-MS). For PCB-77 a toxic equivalency factor (TEF) of 1.5 x 10-3 was calculated based on these correlations. In addition, PCB-118 and PCB-156 levels in abdominal fat (assessed with GC with electron capture detection) and hepatic ethoxyresorufin O-deethylase activities correlated well with the CALUX TEQs in both fatty and cleaned blood plasma extracts, suggesting the TEQ levels in blood offer a good measure for internal dose. Plasma cholesterol and triglyceride levels were determined as a measure of lipid content, in 10-μl aliquots of blood plasma using enzymatic spectrophotometric determination. In conclusion, we have demonstrated that the CALUX assay is a rapid, sensitive assay for assessing the toxic potency of (mixtures of) AhR-active compounds in small aliquots of blood plasma. The limit of detection for the CALUX assay is currently less than 0.1 fmol (32 fg) TEQ, which corresponds with the amount of TEQs present in 0.1 to 1 ml of blood plasma in environmentally exposed species or man.",
keywords = "Biomarker, Blood plasma, Lipids, PHAH, Reporter gene assay",
author = "Murk, {Albertinka J.} and Leonards, {Pim E G} and Bulder, {Astrid S.} and Jonas, {Arjen S.} and Rozemeijer, {Marcel J C} and Denison, {Michael S.} and Koeman, {Jan H.} and Abraham Brouwer",
year = "1997",
month = "8",
doi = "10.1897/1551-5028(1997)016<1583:TCCALE>2.3.CO;2",
language = "English (US)",
volume = "16",
pages = "1583--1589",
journal = "Environmental Toxicology and Chemistry",
issn = "0730-7268",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - The calux (chemical-activated luciferase expression) assay adapted and validated for measuring TCDD equivalents in blood plasma

AU - Murk, Albertinka J.

AU - Leonards, Pim E G

AU - Bulder, Astrid S.

AU - Jonas, Arjen S.

AU - Rozemeijer, Marcel J C

AU - Denison, Michael S.

AU - Koeman, Jan H.

AU - Brouwer, Abraham

PY - 1997/8

Y1 - 1997/8

N2 - A method was developed to isolate lipophilic compounds efficiently from small aliquots of blood plasma and test these for total dioxin-like toxic potency using recombinant rat (H4IIE) and mouse (Hepa1c1c7) hepatoma cell lines, containing the firefly (Photinus pyralis) luciferase gene under trans- activational control of the aryl hydrocarbon receptor (AhR). For this experiment, blood plasma was used originating from eider ducks (Somateria mollissima) that had been dosed with 3,3',4,4'-tetrachlorobiphenyl (PCB-77) or with the technical PCB-mixture Clophen A50. For each sample the CALUX (chemical-activated luciferase expression) response of both the fat- containing organic extract and the fat-free, cleaned extract were compared with data from chemical analyses of these samples. The CALUX responses for the extracts were converted into so-called CALUX TEQs (TCDD equivalents), using a 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) standard curve. The CALUX TEQs in both fatty and cleaned extracts correlated significantly with PCB-77 or PCB-153 levels (depending on the dosage group) determined in blood plasma using gas chromatography-mass spectrometry (GC-MS). For PCB-77 a toxic equivalency factor (TEF) of 1.5 x 10-3 was calculated based on these correlations. In addition, PCB-118 and PCB-156 levels in abdominal fat (assessed with GC with electron capture detection) and hepatic ethoxyresorufin O-deethylase activities correlated well with the CALUX TEQs in both fatty and cleaned blood plasma extracts, suggesting the TEQ levels in blood offer a good measure for internal dose. Plasma cholesterol and triglyceride levels were determined as a measure of lipid content, in 10-μl aliquots of blood plasma using enzymatic spectrophotometric determination. In conclusion, we have demonstrated that the CALUX assay is a rapid, sensitive assay for assessing the toxic potency of (mixtures of) AhR-active compounds in small aliquots of blood plasma. The limit of detection for the CALUX assay is currently less than 0.1 fmol (32 fg) TEQ, which corresponds with the amount of TEQs present in 0.1 to 1 ml of blood plasma in environmentally exposed species or man.

AB - A method was developed to isolate lipophilic compounds efficiently from small aliquots of blood plasma and test these for total dioxin-like toxic potency using recombinant rat (H4IIE) and mouse (Hepa1c1c7) hepatoma cell lines, containing the firefly (Photinus pyralis) luciferase gene under trans- activational control of the aryl hydrocarbon receptor (AhR). For this experiment, blood plasma was used originating from eider ducks (Somateria mollissima) that had been dosed with 3,3',4,4'-tetrachlorobiphenyl (PCB-77) or with the technical PCB-mixture Clophen A50. For each sample the CALUX (chemical-activated luciferase expression) response of both the fat- containing organic extract and the fat-free, cleaned extract were compared with data from chemical analyses of these samples. The CALUX responses for the extracts were converted into so-called CALUX TEQs (TCDD equivalents), using a 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) standard curve. The CALUX TEQs in both fatty and cleaned extracts correlated significantly with PCB-77 or PCB-153 levels (depending on the dosage group) determined in blood plasma using gas chromatography-mass spectrometry (GC-MS). For PCB-77 a toxic equivalency factor (TEF) of 1.5 x 10-3 was calculated based on these correlations. In addition, PCB-118 and PCB-156 levels in abdominal fat (assessed with GC with electron capture detection) and hepatic ethoxyresorufin O-deethylase activities correlated well with the CALUX TEQs in both fatty and cleaned blood plasma extracts, suggesting the TEQ levels in blood offer a good measure for internal dose. Plasma cholesterol and triglyceride levels were determined as a measure of lipid content, in 10-μl aliquots of blood plasma using enzymatic spectrophotometric determination. In conclusion, we have demonstrated that the CALUX assay is a rapid, sensitive assay for assessing the toxic potency of (mixtures of) AhR-active compounds in small aliquots of blood plasma. The limit of detection for the CALUX assay is currently less than 0.1 fmol (32 fg) TEQ, which corresponds with the amount of TEQs present in 0.1 to 1 ml of blood plasma in environmentally exposed species or man.

KW - Biomarker

KW - Blood plasma

KW - Lipids

KW - PHAH

KW - Reporter gene assay

UR - http://www.scopus.com/inward/record.url?scp=0030754631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030754631&partnerID=8YFLogxK

U2 - 10.1897/1551-5028(1997)016<1583:TCCALE>2.3.CO;2

DO - 10.1897/1551-5028(1997)016<1583:TCCALE>2.3.CO;2

M3 - Article

VL - 16

SP - 1583

EP - 1589

JO - Environmental Toxicology and Chemistry

JF - Environmental Toxicology and Chemistry

SN - 0730-7268

IS - 8

ER -